Clinical Trial Update: Buspirone for Anxiety in Autistic Youth [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating buspirone for anxiety in youths with autism. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Autism Spectrum Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anxiety, Autism Spectrum Disorder | Phase 4 | Status: NOT_YET_RECRUITING